To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Bisous For Léo


1800 N Stanley Ave
Los Angeles, CA 90046 USA



Email Address

[email protected]


Bisous For Léo is an Ancillary Arm of the INADcure Foundation, the only U.S. based non-profit dedicated exclusively to the Infantile Neuroaxonal Dystrophy (INAD) community. Bisous For Léo was formed in 2018 as an ancillary arm to support their mission. Together we are funding scientific research for treatments and a cure for INAD and other forms of PLA2G6-related neurodegeneration (PLAN). As explained by Dr. Paul T. Kotzbauer, MD, PhD, and professor in the department of neurology at Washington University School of Medicine, "I have been able to identify a definitive link between Parkinson's disease and INAD. Accumulation of the alpha-synuclein protein, a defining feature of Parkinson's disease, also occurs in INAD, affecting the same regions of the central nervous system. Thus, further understanding of these two neurodegenerative disorders will help to develop new treatments and ultimately a cure.”  As affirmed by J. Paul Taylor, M.D., Ph.D., Faculty Member, Chair of Cell and Molecular Biology Department at St. Jude Children’s Research Hospital and Howard Hughes Medical Institute Investigator, “Mutations in PLA2G6 have been associated with other brain disorders, such as Parkinson’s and Alzheimer’s diseases. Research shows that some INAD patients present Lewy bodies and neurofibrillary tangles in the brain, which suggests a shared pathogenesis. Supporting science aimed towards a better understanding of INAD and PLA2G6 gene mutations could also benefit the other brain diseases in which PLA2G6 has been implicated. Our mission is to kiss INAD goodbye. Facebook: Twitter:

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.